Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma
Advanced Materials · 2024-10 · 36 (40)
DOI: 10.1002/adma.202408016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 20.08.2024. Verfasst von Hengli Lu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China. Hauptthemen laut MEDLINE: Osteosarcoma, Tissue Engineering, Bone Neoplasms, Tissue Scaffolds. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Clinical Research Plan of Shanghai Hospital Development Center, Shanghai Municipal Health Commission Discipline Leader Training Program.
Abstract (Originalsprache)
Osteosarcoma is one of the most dreadful bone neoplasms in young people, necessitating the development of innovative therapies that can effectively eliminate tumors while minimizing damage to limb function. An ideal therapeutic strategy should possess three essential capabilities: antitumor effects, tissue‐protective properties, and the ability to enhance osteogenesis. In this study, self‐assembled Ce‐substituted molybdenum blue (CMB) nanowheel crystals are synthesized and loaded onto 3D‐printed bioactive glass (CMB@BG) scaffolds to develop a unique three‐in‐one treatment approach for osteosarcoma. The CMB@BG scaffolds exhibit outstanding photothermally derived tumor ablation within the near‐infrared‐II window due to the surface plasmon resonance properties of the CMB nanowheel crystals. Furthermore, the photothermally synergistic catalytic effect of CMB promotes the rapid scavenging of reactive oxygen species caused by excessive heat, thereby suppressing inflammation and protecting surrounding tissues. The CMB@BG scaffolds possess pro‐proliferation and pro‐differentiation capabilities that efficiently accelerate bone regeneration within bone defects. Altogether, the CMB@BG scaffolds that combine highly efficient tumor ablation, tissue protection based on anti‐inflammatory mechanisms, and enhanced osteogenic ability are likely to be a point‐to‐point solution for the comprehensive therapeutic needs of osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, P. R. China.
- Department of Bone Tumor Surgery, Shanghai General Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, 200025, P. R. China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, Zhejiang, 325088, P. R. China.
- Shanghai Institute of Materdicine, Shanghai, 200051, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- National Nature Science Foundation of China
- Clinical Research Plan of Shanghai Hospital Development Center
- Shanghai Municipal Health Commission Discipline Leader Training Program
- Shanghai Rising-Star Program
- Health Commission of Anhui Province Health Research Program of Anhui
- Research Program of Shanghai Tenth People's Hospital
- Shanghai Sailing Program
- Guidance Program of Scientific and Technological Innovation of Bengbu City
Zitieren
APA
Lu, H., Li, Z., Duan, Z., Liao, Y., Liu, K., Zhang, Y., Fan, L., Xu, T., Yang, D., Wang, S., Fu, Y., Xiang, H., Chen, Y., & Li, G. (2024). Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma. Advanced Materials, 36(40). https://doi.org/10.1002/adma.202408016
Vancouver
Lu H, Li Z, Duan Z, Liao Y, Liu K, Zhang Y, et al. Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma. Advanced Materials. 2024;36(40). doi:10.1002/adma.202408016
BibTeX
@article{Lu2024,
author = {Lu, Hengli and Li, Zihua and Duan, Zhengwei and Liao, Yuxin and Liu, Kaiyuan and Zhang, Yiwei and Fan, Lin and Xu, Tianyang and Yang, Dong and Wang, Sen and Fu, Yuesong and Xiang, Huijing and Chen, Yu and Li, Guodong},
title = {Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {40},
doi = {10.1002/adma.202408016}
}
EUVIMED